Enzychem Lifesciences Corporation
USPTO PatentsView assignee record - 22 granted patents across 11 technology areas, recorded in grant years 2017–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (Preparations FOR Medical, Dental OR Toiletry Purposes).
The verdict
According to USPTO PatentsView, Enzychem ranks #13,410 of 49,997 tracked US assignees by granted-patent volume, with 22 patents across 11 technology areas.
- #13,410
- of 49,997 US assignees by volume
- 47th percentile
- by Innovation Score (34.3/100)
- 13.3
- avg claims per patent
- +133%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R13410 · Foreign Corporation #13,410 · 22 grants
GRANTS-SMALL · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL
- GRANTS-SMALL 22 grants
- MID-PACK #13,410/49,997
- PHOTO-FINISH Eberhard Karls…
- CPC-FOCUS A61K · 11 areas
- INNOV-THIN 34.3/100
- CLAIMS-RICH 13.3 claims/avg
- TYPE-FRNCORP Foreign Corp
- VEL-SURGE +133% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Eberhard Karls Universitaet Tuebingen Medizinische Fakultaet (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Enzychem’s 34.3 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Enzychem
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Enzychem Lifesciences · this assignee
Enzychem Lifesciences · this assignee
34 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Enzychem's Innovation Score is 34.3/100 (47th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Enzychem?
Each dot is one of Enzychem’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Enzychem’s own 13.3 claims/patent is ABOVE the 12.1 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.
Where Enzychem's grants concentrate
Enzychem Lifesciences Corporation is a focused PatentsView assignee: 11 CPC subclasses with 90.9% of grants classified under A61K (Preparations FOR Medical, Dental OR Toiletry Purposes). Peak complete grant year is 2020 (6 grants) versus a trough of 1 in 2023. By volume, Enzychem sits between Elkamet Kunststofftechnik GMBH and Edmonds Outdoors, LLC.
Enzychem's three-year grant acceleration
Enzychem Lifesciences Corporation shows 5 grants in 2022–2024 against only 9 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at Enzychem's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Elkamet Kunststof…
Elkamet Kunststofftechnik GMBH
22 patents
- Emerson Paradigm…
Emerson Paradigm Holding LLC
22 patents
- Emtensor
Emtensor GMBH
22 patents
- Enterpriseweb
Enterpriseweb LLC
22 patents
- Erni Production &…
Erni Production GmbH & Co. KG
22 patents
- Esbatech an Alcon…
ESBATech, an Alcon Biomedical Research Unit LLC
22 patents
- Eberhard Karls Un…
Eberhard Karls Universitaet Tuebingen Medizinische Fakultaet
22 patents
- Edmonds Outdoors
Edmonds Outdoors, LLC
22 patents
- Enzychem Lifescie… ◀
Enzychem Lifesciences Corporation
22 patents
What this shows Enzychem holds 22 patents at rank #13,399, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Enzychem
By rank, the assignees closest to #13,399 in granted patent volume.
- Elkamet Kunststofftechnik GMBH #13,395 · 22 patents
- Emerson Paradigm Holding LLC #13,396 · 22 patents
- Emtensor GMBH #13,397 · 22 patents
- Enterpriseweb LLC #13,398 · 22 patents
- Erni Production GmbH & Co. KG #13,400 · 22 patents
- ESBATech, an Alcon Biomedical Research Unit LLC #13,401 · 22 patents
- Eberhard Karls Universitaet Tuebingen Medizinische Fakultaet #13,402 · 22 patents
- Edmonds Outdoors, LLC #13,403 · 22 patents
Leaders in A61K (Preparations FOR Medical)
Other assignees with the most granted patents in Enzychem's primary technology class.
- The Regents of the University of California 1,779 in class
- L'Oreal 1,250 in class
- Novartis AG 988 in class
- The Procter & Gamble Company 985 in class
- The Board of Regents of the University of Texas System 950 in class
- The United States of America, as represented by the Secretary, Department of Health and Human Services 813 in class
- The Trustees of the University of Pennsylvania 768 in class
- Merck Sharp & Dohme LLC 760 in class
Enzychem's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
34 47th percentile higher than 47% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2017 | 3 | 13.6% |
| 2018 | 3 | 13.6% |
| 2020 | 6 | 27.3% |
| 2021 | 3 | 13.6% |
| 2022 | 3 | 13.6% |
| 2023 | 1 | 4.5% |
| 2024 | 1 | 4.5% |
| 2025partial year | 2 | 9.1% |
Which technologies does Enzychem Lifesciences Corporation patent most?
Top 11 of 11 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Enzychem Lifesciences Corporation's patent record in context - here's where to go next.
- Enzychem Lifesciences Corporation's lead technology class is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes), 90.9% of its portfolio - see every assignee active in that class. Explore A61K
- Ranked #13,410 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Enzychem Lifesciences Corporation against Elkamet Kunststofftechnik GMBH, an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 34.3/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.